Published in
American Society of Hematology, Blood, Supplement 1(140), p. 9019-9020, 2022
DOI: 10.1182/blood-2022-168303
Links
Tools
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Journal article published in 2022 by
Ahmad Ghorab 
,
Mark R. Litzow,
Naseema Gangat,
Aref Al-Kali,
Mithun V. Shah,
Hemant S. Murthy,
Ayalew Tefferi,
Hassan B. Alkhateeb,
Kebede Begna,
Mrinal M. Patnaik,
James M. Foran,
Talha Badar
,
Mark R. Litzow,
Naseema Gangat,
Aref Al-Kali,
Mithun V. Shah,
Hemant S. Murthy,
Ayalew Tefferi,
Hassan B. Alkhateeb,
Kebede Begna,
Mrinal M. Patnaik,
James M. Foran,
Talha Badar
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 